RE: Novacyt Yourgene Partnership23 Apr 2020 11:30
Manchester, UK - 20 April 2020: Yourgene (AIM: YGEN), a leading international molecular diagnostics group, announces a trading update for the year ended 31 March 2020.
Revenues for the year ended 31 March 2020 were £16.6m (2019: £8.9m), up 86% compared to the previous year, and does not include £0.4m of orders for March that fell into the new financial year due to COVID-19 transport restrictions. The revenue increase reflects organic growth of approximately 36%; 11 months contribution from Elucigene Diagnostics, acquired on 26 April 2019; and three weeks' contribution from the Company's French NIPT distribution business, acquired on 10 March 2020.